A link between the reduced CBX5 expression and the altered expression of genes where RNAPII pause–release is a rate-limiting step was also observed in MS patient T cells, as demonstrated by reanalyzing a set of published RNA-seq data (22). Here, CBX5 is linked to myeloid sarcoma.